Clinical Trial Update: Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating precision cell immunotherapy in combination with transcatheter arterial chemoembolization for advanced liver cancer; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Precision Cells

Snippet

Sponsor: Shanghai International Medical Center | Conditions: Precision Cells, Transcatheter Arterial Chemoembolization | Phase 1, Phase 2 | Status: UNKNOWN